2024 Laboratory Reimbursement Trends and What to Expect in 2025
Revenue cycle management experts weigh in on the biggest developments of 2024 and how labs can best prepare for 2025 and beyond
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Revenue cycle management experts weigh in on the biggest developments of 2024 and how labs can best prepare for 2025 and beyond
What do lab professionals need to do to ensure sufficient documentation for billing clinical laboratory and pathology services?
Performing your own audit to verify compliance and identify problems is one key to achieving a successful FDA audit.
In last month’s key cases, Illumina and Guardant seek to dismiss lawsuit related to trade secrets and breach of contract.
A recent SCOTUS ruling on a healthcare fraud case could help defend labs against baseless whistleblower cases.
Labs will have to submit Z-Codes with every molecular pathology testing code billed to UnitedHealthcare, starting Aug. 1.
Last month’s key cases involved the outcome of a UHC lawsuit and fines for misleading claims about a COVID-19 test.
Individualized quality control plans offer flexibility and the capacity to seamlessly adopt new nonwaived tests, practices, and technologies.
Recent developments pose reimbursement and compliance challenges for billing and coding infectious disease testing—here’s how to manage them.
Though UDT-related enforcement actions predominate, an uncommon vendor-related case was in the mix this month.
Recent cases involve COVID-19 fraud, UDTs, and the latest HIPAA Right of Access settlement.